Consolidated Cash Flow Statement

for the year ended March 31, 2025

in ‘000s
    Year ended
31.03.2025
Year ended
31.03.2024
Cash flow from/(used in) operating activities      
Profit/(loss) before taxes   694,640,235 596,839,961
Adjustments for:      
Depreciation and amortisation   26,903,750 19,958,856
Net (appreciation)/depreciation on investments   (1,023,190) 16,172,037
Provision in respect of non-performing and other assets   41,272,474 9,635,716
General provision for standard assets   7,011,427 11,658,491
Provision for contingencies & others   (7,227,370) 8,780,202
(Profit)/loss on sale of fixed assets   (439,077) (144,093)
Employees stock options expense   7,901,495 7,029,081
  (i) 769,039,744 669,930,251
Adjustments for:      
(Increase)/decrease in investments   75,014,144 167,355,354
(Increase)/decrease in advances   (1,640,197,486) (1,782,646,848)
Increase/(decrease) in deposits   1,980,574,515 2,329,930,107
(Increase)/decrease in other assets   (5,176,415) 18,818,794
Increase/(decrease) in other liabilities and provisions1   229,962,676 302,893,172
  (ii) 640,177,434 1,036,350,579
Refund/(payment) of direct taxes (iii) (181,164,596) (133,436,047)
Net cash flow from/(used in) operating activities (i)+(ii)+(iii) (A) 1,228,052,582 1,572,844,783
Cash flow from/(used in) investing activities      
Purchase of fixed assets   (47,700,055) (36,785,464)
Proceeds from sale of fixed assets   646,115 698,893
(Purchase)/sale of held to maturity securities   (725,829,665) (1,423,224,353)
Net cash flow from/(used in) investing activities (B) (772,883,605) (1,459,310,924)
Cash flow from/(used in) financing activities      
Proceeds from issue of share capital (including ESOPs)   14,375,199 11,708,675
Proceeds from long-term borrowings   404,464,948 391,968,191
Repayment of long-term borrowings   (399,331,062) (391,468,771)
Net proceeds/(repayment) of short-term borrowings   106,795,922 181,423,005
Dividend paid   (70,412,665) (55,985,964)
Net cash flow from/(used in) financing activities (C) 55,892,342 137,645,136
Effect of exchange fluctuation on translation reserve (D) 1,484,292 4,234,435
Net increase/(decrease) in cash and cash equivalents (A) + (B) + (C) + (D)   512,545,611 255,413,430
Cash and cash equivalents at beginning of the year   1,627,689,026 1,364,564,928
Add: Addition of ICICI Lombard General Insurance Company
Limited and I-Process Services (India) Private Limited as a
subsidiary in consolidation during the year
  - 7,710,668
Cash and cash equivalents at end of the year   2,140,234,637 1,627,689,026

1. Including adjustements for increase/(decrease) in Policyholders' funds.

2. Cash and cash equivalents include cash in hand, foreign currency notes, rupee digital currency, balances with RBI, balances with other banks and money at call and short notice.

As per our Report of even date.

For B S R & Co. LLP
Chartered Accountants
ICAI Firm Registration no.:
101248W/W-100022

Ashwin Suvarna
Partner
Membership no.: 109503

For C N K & Associates LLP
Chartered Accountants
ICAI Firm Registration no.:
101961W/W100036

Manish Sampat
Partner
Membership no.: 101684

For and on behalf of the Board of Directors

S. Madhavan
Director
DIN-06451889
 

Rakesh Jha
Executive Director
DIN-00042075

Anindya Banerjee
Group Chief Financial Officer

Sandeep Bakhshi
Managing Director & CEO
DIN-00109206
 

Sandeep Batra
Executive Director
DIN-03620913

Prachiti Lalingkar
Company Secretary

Ajay Kumar Gupta
Executive Director
DIN-07580795

Laxminarayan Achar
Chief Accountant

Mumbai
April 19, 2025